Skip to main content

Idarubicin

Generic name: idarubicin (EYE da ROO bi sin)
Brand name: Idamycin PFS, Idamycin
Dosage forms: intravenous solution (1 mg/mL)
Drug class: Antibiotics / antineoplastics

Medically reviewed by Drugs.com on Dec 10, 2020. Written by Cerner Multum.

What is idarubicin?

Idarubicin is used in combination chemotherapy to treat acute myeloid leukemia (AML), a type of blood cancer.

Idarubicin may also be used for purposes not listed in this medication guide.

Warnings

Idarubicin can increase your risk of bleeding or infection. Call your doctor if you have unusual bruising or bleeding, or new signs of infection (fever, chills, tiredness).

Idarubicin may cause dangerous effects on your heart, especially if you have heart problems, if you have received certain cancer drugs in the past, or if you are over 60.

Seek medical attention right away if you have chest pain, irregular heartbeats, shortness of breath, swelling, or rapid weight gain.

Before taking this medicine

Idarubicin may cause dangerous effects on your heart. especially if you have heart problems, if you have received certain cancer drugs in the past, or if you are over 60.

Tell your doctor if you have ever had:

  • heart problems;

  • radiation treatment;

  • chemotherapy with doxorubicin, daunorubicin, epirubicin, idarubicin, or mitoxantrone;

  • bone marrow suppression;

  • liver or kidney disease;

  • gout;

  • anemia (low red blood cells); or

  • sepsis (a severe reaction to an infection).

It is not known whether idarubicin will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

You should not breastfeed while using this medicine.

How is idarubicin given?

Idarubicin is given as an infusion into a vein. A healthcare provider will give you this injection.

Idarubicin is usually given together with other cancer medicines. You may be given other medications to prevent nausea, vomiting, or infections.

Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when idarubicin is injected.

If any of this medication accidentally gets on your skin, wash it thoroughly with soap and warm water.

Idarubicin can increase your risk of bleeding or infection. You will need frequent medical tests. Your liver, kidney, and heart function may also need to be checked.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your idarubicin injection.

What happens if I overdose?

Since idarubicin is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while receiving idarubicin?

Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.

Avoid activities that may increase your risk of bleeding or injury. Use extra care to prevent bleeding while shaving or brushing your teeth.

Idarubicin side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Idarubicin may cause dangerous effects on your heart. Tell doctor right away if you have chest pain, shortness of breath (even with mild exertion), swelling, or rapid weight gain.

Call your doctor at once if you have:

  • irritation or skin changes where the injection was given;

  • fever, chills, tiredness, feeling light-headed or short of breath.

  • pale skin, easy bruising or bleeding (nosebleeds, bleeding gums);

  • pain, blisters, bleeding, or severe rash on the palms of your hands or the soles of your feet;

  • sores or white patches in or around your mouth; or

  • severe nausea, vomiting, stomach cramps, or diarrhea.

Common side effects may include:

  • nausea, vomiting, stomach pain, diarrhea;

  • mouth sores;

  • bleeding;

  • headache;

  • rash; or

  • hair loss.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Idarubicin dosing information

Usual Adult Dose for Acute Myeloid Leukemia:

12 mg/m2 daily for 3 days by slow (10 to 15 min) IV administration in combination with cytarabine
Maximum recommended cumulative lifetime dose for the IV formulation: 150 mg/m2

In patients with unequivocal evidence of leukemia after the first induction course, a second course may be administered.

Comment:
-Administration of the second course should be delayed in patients who experience severe mucositis until recovery has occurred, and a dose reduction of 25% is recommended.

Use: For the treatment of acute myeloid leukemia (AML) in combination with other approved antileukemic drug (including French-American-British [FAB] classifications M1 through M7)

Usual Adult Dose for Acute Nonlymphocytic Leukemia:

12 mg/m2 daily for 3 days by slow (10 to 15 min) IV administration in combination with cytarabine
Maximum recommended cumulative lifetime dose for the IV formulation: 150 mg/m2

In patients with unequivocal evidence of leukemia after the first induction course, a second course may be administered.

Comment:
-Administration of the second course should be delayed in patients who experience severe mucositis until recovery has occurred, and a dose reduction of 25% is recommended.

Use: For the treatment of acute myeloid leukemia (AML) in combination with other approved antileukemic drug (including French-American-British [FAB] classifications M1 through M7)

What other drugs will affect idarubicin?

Tell your doctor about all other cancer medicines you have received in the past 7 months, especially:

This list is not complete. Other drugs may affect idarubicin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Does Idarubicin interact with my other drugs?

Enter other medications to view a detailed report.

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.